(Q79440232)

English

Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study

scientific article published on 01 January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177199%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177199%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

based on heuristic

inferred from title

author name string

Alexander McIntyre

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177199%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Alain Gendron

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177199%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Amanda McIntyre

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177199%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 January 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177199%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Depression and Anxiety

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177199%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177199%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

487-494

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177199%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177199%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Preliminary experience with adjunctive quetiapine in patients receiving selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of olanzapine in social anxiety disorder: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

To combine or not to combine? A literature review of antidepressant combination therapy

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacologic management of difficult-to-treat depression in clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose risperidone and quetiapine as monotherapy for comorbid anxiety and depression.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Comorbid depression and anxiety spectrum disorders

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

The assessment of anxiety states by rating

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Current therapy issues and unmet clinical needs in the treatment of schizophrenia: a review of the new generation antipsychotics

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Remission onset and relapse in depression. An 18-month prospective study of course for 100 first admission patients

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone augmentation of selective serotonin reuptake inhibitors in major depression.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjunctive quetiapine for treatment-resistant adolescent major depressive disorder: a case series

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of olanzapine for treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of quetiapine in generalized social anxiety disorder: results from an open-label study.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Course of depression in patients with comorbid anxiety disorders.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized single-blind, multicenter trial comparing the efficacy and safety of paroxetine with and without quetiapine therapy in depression associated with anxiety.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20275

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DA.20275

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177199%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17177199%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79440232&oldid=1599885752"